Response to ‘Aprepitant and fosaprepitant decrease the effectiveness of hormonal contraceptives’

E-ISSN： 1365-2125|84|3|604-604

ISSN： 0306-5251

Source： BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.84, Iss.3, 2018-03, pp. : 604-604

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Aprepitant and fosaprepitant decrease the effectiveness of hormonal contraceptives

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 84, Iss. 3, 2018-03 ,pp. : 602-603

John Wiley & Sons Inc

Access to resources Recommend Favorite

Extended and continuous use of hormonal contraceptives to reduce menstruation

By Wiegratz Inka Kissler Stefan Kuhl Herbert Kaufmann Manfred

Women's Health, Vol. 2, Iss. 5, 2006-09 ,pp. : 705-716

Future Medicine

Access to resources Recommend Favorite

Equivalent Dynamic Human Brain NK1‐Receptor Occupancy Following Single‐Dose i.v. Fosaprepitant vs. Oral Aprepitant as Assessed by PET Imaging

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 2, 2012-08 ,pp. : 243-250

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drugs for healthy people: The culture of testing hormonal contraceptives for women and men

By Oudshoorn Nelly

Clio Medica/The Wellcome Series in the History of Medicine, Vol. 66, Iss. 1, 2002-04 ,pp. : 123-140

Rodopi

Access to resources Recommend Favorite

Prediction of Response to Hormonal Treatment in Metastatic Breast Cancer

Oncology, Vol. 63, Iss. 4, 2002-11 ,pp. : 309-316

Karger

Access to resources Recommend Favorite